The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

Paul Chapman, Lee Cranmer, W. G. Dixon, K. L. Hyrich, John R. Patterson, D. P.M. Symmons, Mary Toporcer, Michael J. Mastrangelo

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)11-19
Number of pages9
JournalSeminars in Oncology
Volume37
Issue number1
DOIs
StatePublished - Feb 1 2010

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this